Esurgi
  • Home
  • Our Story
  • Our Product
  • Therapy
  • Blog Page
  • Contact Us
Select Page
Effect of formal education and socioeconomic background on Alzheimer’s disease

Effect of formal education and socioeconomic background on Alzheimer’s disease

by Gaganpreet Kaur | Mar 6, 2021 | Alzheimer's Disease

In 2015, with 47 million people suffering from Alzheimer’s disease (AD) and dementia, the World Health Organization and Alzheimer’s Disease International recognized AD as a global health priority (1). The prevalence of AD and dementia patients is projected to increase...
Race, Culture, and Alzheimer’s Disease

Race, Culture, and Alzheimer’s Disease

by Smriti Haria | Feb 19, 2021 | Alzheimer's Disease, Medical Officers, Prescribers

As of 2014, 1.6% of the American population, 5 million people, were afflicted by Alzheimer’s Disease (AD) and other related dementias. This number is only expected to grow with a prediction that by 2060, AD and other dementias will affect 3.3% of Americans [1]. Like...
Diabetes and Alzheimer’s disease

Diabetes and Alzheimer’s disease

by Gaganpreet Kaur | Feb 1, 2021 | Alzheimer's Disease, I. Issues

Alzheimer’s disease (AD), a neurodegenerative disorder, is the leading cause of dementia and is characterized by cognitive impairments including memory loss. Currently, more than 5 million Americans are suffering from AD and this number is projected to increase to 14...
Using Yoga and Meditation in Alzheimer’s Disease Patients

Using Yoga and Meditation in Alzheimer’s Disease Patients

by Sophie Gilbert | Jan 22, 2021 | Alzheimer's Disease, Physical Therapy / Medicine and Rehabilitation

The current ‘gold-standard’ in treating and preventing the progression of Alzheimer’s Disease (AD) without, or in coordination with, prescription medication is memory-enhancement training (MET) (1). MET programs utilize techniques such as mnemonics and repetition to...
The Fluid Biomarkers of Alzheimer’s Disease

The Fluid Biomarkers of Alzheimer’s Disease

by Eden Sheinin | Jan 20, 2021 | Alzheimer's Disease, Medical Officers

Alzheimer’s disease (AD) is one of the most prevalent illnesses in the U.S. One in three seniors die due to AD or another dementia, making it the sixth leading cause of death nationally. (1) There are no clinically proven therapies to treat AD. Diagnosis has...
The Underlying Biology of Alzheimer’s Disease

The Underlying Biology of Alzheimer’s Disease

by Emily Armitage | Jan 14, 2021 | Alzheimer's Disease, I. Issues

Stefan Merrill Block’s grandmother forgot her age, her daughter, and Stefan when he was twelve. He wrote about his grandmother’s experience with Alzheimer’s disease (AD) for the New Yorker (3), with a focus on his grandmother’s “cognitive return to birth,” called...
« Older Entries

Blog Posts

Categories

  • I. Issues
    • Alzheimer's Disease
    • Anterior Cruciate Ligament Injury
    • Low Back Pain
    • Prescription Support
  • II. Roles
    • Athletic
    • Medical Officers
    • Physical Therapy / Medicine and Rehabilitation
    • Prescribers
  • III. Solutions
    • Biostabilizer
    • Joint Spy
    • LeMo
  • IV. Others

Follow Us

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
© 2015 - 2020 Esurgi. ALL RIGHTS RESERVED